Toxicology Reports (Jan 2022)
Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510]
- Henrique Pott-Junior,
- Mônica Maria Bastos Paoliello,
- Alice de Queiroz Constantino Miguel,
- Anderson Ferreira da Cunha,
- Caio Cesar de Melo Freire,
- Fábio Fernandes Neves,
- Lucimar Retto da Silva de Avó,
- Meliza Goi Roscani,
- Sigrid De Sousa dos Santos,
- Silvana Gama Florêncio Chach´
Affiliations
- Henrique Pott-Junior
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil; Corresponding author.
- Mônica Maria Bastos Paoliello
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461 Bronx, NY, United States
- Alice de Queiroz Constantino Miguel
- University Hospital of the Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Anderson Ferreira da Cunha
- Department of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Caio Cesar de Melo Freire
- Department of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Fábio Fernandes Neves
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Lucimar Retto da Silva de Avó
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Meliza Goi Roscani
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Sigrid De Sousa dos Santos
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Silvana Gama Florêncio Chach´
- Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil
- Journal volume & issue
-
Vol. 9
p. 1023